Pharmacogenomics has progressed greatly from innovations in technologies, including faster computers for processing big data sets and next generation .. Read more gene sequencing and annotation. But above, this field has advanced through all through the diligent learning of clinicians and research on how to connect clinical and genetic data to safe and effective treatments. In addition, development scientists have gained a deeper appreciation of the differences (and commonalities) between healthy and disease states. Each connection has been hard-won with each learning cycle yielding more innovations, novel targets, and drugs validated through clinical trials. We anticipate continued growth of pharmacogenomics to all therapeutic areas. If you are a clinician, research scientist, or regulator this conference is one you won’t want to miss. Please join us for the world’s most informative conference for precision oncology leaders from with leaders from academia, biotech, pharmaceuticals, diagnostics, clinical research, healthcare and regulatory bodies.
- [ Users who have shown interest for this Event ]
- + Add me as user
- Share your Experience